Clinical experience with survivin as a biomarker for urothelial bladder cancer.
Horstmann
Marcus
M
Department of Urology, Eberhard Karls University Tuebingen, Hoppe-Seyler -Str. 3, 72076, Tuebingen, Germany. marcushorstmann@gmx.ch
Bontrup
Heike
H
Hennenlotter
Jörg
J
Taeger
Dirk
D
Weber
Anne
A
Pesch
Beate
B
Feil
Gerhard
G
Patschan
Oliver
O
Johnen
Georg
G
Stenzl
Arnulf
A
Brüning
Thomas
T
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000652:urine*; D002278:Carcinoma in Situ / Q000473:pathology / Q000652:urine*; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000473:pathology / Q000652:urine*; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D008297:Male; D008869:Microtubule-Associated Proteins / Q000652:urine*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging* / Q000401:mortality / Q000473:pathology; D009367:Neoplasm Staging; D010865:Pilot Projects; D011379:Prognosis; D011446:Prospective Studies; D012333:RNA, Messenger / Q000032:analysis; D012372:ROC Curve; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012737:Sex Factors; D016019:Survival Analysis; D000077022:Survivin; D014463:Ultrasonography; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology / Q000652:urine*
C107489:BIRC5 protein, human; D014408:Biomarkers, Tumor; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D012333:RNA, Messenger; D000077022:Survivin